MIPS Participation in 2017
At what level will your practice participate in MIPS this year? Here’s what you need to know to start documenting performance data this year.
Meaningful Dollars Saved with Bundled Payments
Bundled payments led to a "win-win-win-win" reality for one Texas hospital struggling to contain costs for joint replacement surgeries. In this audio interview, two physicians discuss the complexities and benefits of bundled payments.
Predictive Modeling for Spine Surgeries in the MACRA Era
Predictive modeling data can steer physicians toward making healthcare decisions that have positive outcomes for patients.
Value-Based Care for the High-Need Patient
Improving care for high-need, high-cost patients is an imperative for patients and the healthcare system. Programs are in development, NEJM perspective reports.
Collaborative Care in the MACRA Era
Providers with a limited practice scope should be prepared to participate in collaborative care or reimbursement under MACRA could suffer, Dr. Edward Lin says.
Medicare’s QPP Not Yet Ready for Rheumatologists
Rheumatologists face unique challenges not fully addressed in CMS' Quality Payment Program, says CSRO's Dr. Michael Schweitz. Dr. Schweitz addresses these challenges in this blog post.
The Most Common Reasons Driving Readmissions in TJA
Prem N. Ramkumar, M.D., the author of a recent analysis on readmission rates in TJA, speaks with Rheumatology Network about why readmission rates matter.
Physicians should understand the key features of MACRA and changes that lie ahead, say Duke University healthcare policy experts writing in JAMA
Physicians should understand the key features of MACRA and changes that lie ahead, say Duke University healthcare policy experts writing in JAMA.
Weighing the Value of Opioids and TKA Outcomes
A new modeling study suggests that the opioid medications tramadol and oxycodone are not generally cost-effective for knee osteoarthritis.